DIagnostic products
Precision drugs

Diagnostic tests that analyse stromal biomarkers, to diagnose and prognose tumor invasiveness

Novel stroma-targeted precision drugs, to fight against invasive tumors

Diagnostics tests that analyse stromal biomarkers

DIAGNOSTICS

Novel stroma-targeted precision drugs

PRECISION DRUGS

INVASIVE CANCER DIAGNOSTICS

ONCOMATRYX scientists have discovered and validated novel stromal biomarkers for accurate diagnosis and prognosis of invasive tumors.

col11A1en
bot-invas
bot_bladder
careers
Send your application

Join our team in BOSTON or BILBAO.

BLOG. Last ONCOMATRYX team posts, news and releases

  • war on cancer stroma

    “I declare war on cancer stroma”

    LAUREANO SIMON, Oncomatryx CEO, declares war on tumor microenvironment. “We envysion a new era where cancer in general and invasive tumors in particular will be beaten with orchestrated combinations of precision
  • World ADC Berlin

    World ADC Berlin

    6th World ADC Summit. 8th-10th February 2016. Berlin (Germany). ONCOMATRYX will be attending World ADC Berlin. Poster Presentation:  “OMTX705, a powerful stroma-targeting ADC to treat invasive tumors” by Myriam Fabre, PhD. If you
    Read more

By continuing to use the site, you agree to the use of cookies. Continue, scroll or accept. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close